Publication | Closed Access

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

Renal FunctionHepatologyLiver PhysiologyChronic Kidney DiseasePharmacologyPharmacotherapyMedicineDrug-induced Liver InjuryEnd-stage Renal DiseaseHepatic Cirrhosis